Trade OXFORD BIOMEDICA PLC ORD 50P - OXB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.174 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.025295% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.003377% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.423 |
| Open | 3.408 |
| 1-Year Change | -22.56% |
| Day's Range | 3.348 - 3.658 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 3.398 | 0.055 | 1.65% | 3.343 | 3.523 | 3.283 |
| Jul 24, 2024 | 3.403 | 0.095 | 2.87% | 3.308 | 3.428 | 3.283 |
| Jul 23, 2024 | 3.438 | 0.040 | 1.18% | 3.398 | 3.453 | 3.293 |
| Jul 22, 2024 | 3.338 | -0.010 | -0.30% | 3.348 | 3.498 | 3.293 |
| Jul 19, 2024 | 3.323 | 0.020 | 0.61% | 3.303 | 3.368 | 3.303 |
| Jul 18, 2024 | 3.303 | -0.040 | -1.20% | 3.343 | 3.438 | 3.278 |
| Jul 17, 2024 | 3.313 | -0.070 | -2.07% | 3.383 | 3.398 | 3.273 |
| Jul 16, 2024 | 3.358 | 0.015 | 0.45% | 3.343 | 3.438 | 3.308 |
| Jul 15, 2024 | 3.373 | 0.000 | 0.00% | 3.373 | 3.433 | 3.308 |
| Jul 12, 2024 | 3.433 | 0.095 | 2.85% | 3.338 | 3.453 | 3.298 |
| Jul 11, 2024 | 3.408 | 0.120 | 3.65% | 3.288 | 3.423 | 3.228 |
| Jul 10, 2024 | 3.263 | 0.035 | 1.08% | 3.228 | 3.323 | 3.193 |
| Jul 9, 2024 | 3.218 | -0.060 | -1.83% | 3.278 | 3.323 | 3.188 |
| Jul 8, 2024 | 3.273 | 0.030 | 0.93% | 3.243 | 3.348 | 3.223 |
| Jul 5, 2024 | 3.228 | -0.040 | -1.22% | 3.268 | 3.288 | 3.228 |
| Jul 4, 2024 | 3.288 | 0.239 | 7.84% | 3.049 | 3.313 | 3.049 |
| Jul 3, 2024 | 3.084 | 0.040 | 1.31% | 3.044 | 3.118 | 2.994 |
| Jul 2, 2024 | 3.009 | 0.105 | 3.62% | 2.904 | 3.059 | 2.904 |
| Jul 1, 2024 | 2.924 | -0.030 | -1.02% | 2.954 | 3.024 | 2.924 |
| Jun 28, 2024 | 2.939 | -0.065 | -2.16% | 3.004 | 3.044 | 2.894 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Oxford BioMedica plc Company profile
About Oxford BioMedica plc
Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver diseases. The Company's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401. The Company has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.
Financial summary
BRIEF: For the six months ended 30 June 2021, Oxford BioMedica plc revenues increased from £34M to £81.3M. Net income totaled £18.1M vs. loss of £6.7M. Revenues reflect Europe segment increase from £19M to £70.3M. Net Income reflects Platform segment income totaling £24.4M vs. loss of £3.1M. Basic Earnings per Share excluding Extraordinary Items increased from -£0.09 to £0.22.
Equity composition
10/2003, Rights Issue, 27 new shs for every 50 shs held @ GBP 0.17 (Fct:1.54). 03/2001, Rights Issue, 1 new share for every 9 shs held @ GBP 0.55 (Fct:1.111111). 03/1998, Rights Issue, 1 new share for every 4 shs held @ GBP 0.10 (Fct:1.076). 05/2014, Priority Issue, 1 new shares for every 5 shares held @ GBp 2 (Factor:1).
| Industry: | Bio Therapeutic Drugs |
Windrush Court
Transport Way
OXFORD
OXFORDSHIRE OX4 6LT
GB
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com